AAM
BIIB icon

Arabesque Asset Management’s Biogen BIIB Stock Holding History

Arabesque Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,328
Closed -$1.04M – 165
2021
Q4 		$1.04M Sell
4,328
-1,689
-28% -$434K 0.3% 121
2021
Q3 		$1.7M Buy
6,017
+4,317
+254% +$1.41M 0.57% 83
2021
Q2 		$589K Buy
+1,700
New +$515K 0.25% 109

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Arabesque Asset Management's BIIB Position: Q1 2022 in Review

Arabesque Asset Management sold out of Biogen (BIIB) in Q1 2022, closing a stake of 4,328 shares — an estimated $1.04M sold.

Arabesque Asset Management first reported a position in BIIB in Q2 2021 and held it in 3 quarters. The position peaked at $1.7M in Q3 2021. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Arabesque Asset Management reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Arabesque Asset Management sold 4,328 Biogen shares in Q1 2022, an estimated $1.04M.
  • Arabesque Asset Management first reported a position in Biogen in Q2 2021 and held it in 3 quarters.
  • Arabesque Asset Management's Biogen position peaked at $1.7M in Q3 2021.
  • 952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Arabesque Asset Management's 13F filing for Q1 2022, filed 16 May 2022.